Add To My Watchlist
View My Watchlist

Green Zone Power Rating: 50 Neutral

Action to take: WATCH
Neutral stocks are expected to perform in line with the market over the next 12 months.
50
Price Based
Momentum
76
Size
1
Volatility
95
Fundamental Based
Value
9
Quality
59
Growth
60
Positive Factors (Top 20%)
Volatility: Low-volatility stocks tends to outperform high-volatility stocks.
Negative Factors (Bottom 20%)
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Value: Stocks with the highest valuations tend to produce weak or negative forward returns.
Collapse Detail
NYSE%3AMRK charts & data provided by TradingView

Latest Insights on MRK

gold precious metals stock A-Mark Precious Metals Gain Traction — 1 Stock Profits as Investors Hedge
by Matthew Clark December 30, 2022 Money & Markets Daily
With inflation still front of mind, investors are scrambling to find a hedge. Precious metals stocks like this one will benefit.
biotech stock to buy SIGA Technologies biotech REIT biotech value investor Novo Nordisk stock NVO Be a Genomics Landlord With One High-Growth Biotech REIT
by Adam O'Dell September 3, 2021 Investing
Genomics has true potential, and that opens up many avenues to invest in this mega trend. Here's a high-growth biotech REIT worth a look.
HART ETF 10K Baby Boomers a Day Will Boost This Heart-Healthy ETF
by Adam O'Dell August 13, 2021 Investing
Every day 10,000 baby boomers hit age 65. One fund will rise as this age group spends more on health care.
FAANG stocks FAANG FAANG Earnings Galore: What to Expect for Q1 Numbers
by Matthew Clark April 25, 2021 Markets
This is a huge week on the earnings calendar, with several big-name, particularly FAANG, companies set to report quarterly numbers. In this week's Week Ahead, we look at those numbers as well as higher-than-expected consumer confidence.
Merck stock High-Risk Big Pharma Stock to Avoid: Merck & Co.
by Charles Sizemore March 29, 2021 Investing
Merck is an innovative pharma company — but its stock is high-risk. Charles Sizemore examines Merck stock rating to explain more.